Datafin

Data-driven stock analysis platform for global investors.

Sitemap
HomeScreenerValuationSector Analysis
Resources
LibraryDatafin GuideMetric MethodologyValuation MethodologiesFAQPricingWho Is Datafin?Communication
Legal
Privacy PolicyTerms of UseCookie PolicyKVKK NoticeRefund Policy
Data Sources

Financial data sourced from official regulatory filings and verified market data providers. Metrics calculated using GAAP/IFRS standards.

Disclaimer

The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

Investment decisions involve risk. Verify data independently and consult a licensed advisor when needed.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved.

Last updated: April 2026

EBO FINANCIAL STATEMENTS

Ebos Group Ltd — balance sheet, income statement and cash flow trends

EBOEbos Group Ltd

🇦🇺 Australia · AU · Healthcare · Medical Distribution

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income
05 B10 B15 B202020212022202320242025

Profit Funnel

Q2 2025 · TTM
Revenue14.2 B NZDGross Profit2 B NZD · 14%Operating Income351.8 M NZD · 2%Pre-tax Income336 M NZD · 2%Net Income249.7 M NZD · 2%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue14.2 B NZD—
Gross Profit2 B NZD—
Operating Income351.8 M NZD—
EBITDA603.8 M NZD—
Net Income249.7 M NZD—

Peer Comparison· Medical Distribution

CompanyRev. GrowthGross MarginEBITDA MarginNet Margin
EBO1.7%14.0%4.3%1.8%
SELEC11.4%9.3%3.1%0.6%
HSIC5.6%29.7%7.5%3.0%
CAH12.8%3.7%1.2%0.6%
COR5.9%3.5%1.5%0.8%
MCK12.4%3.6%1.7%1.2%
Industry median11.4%5.5%1.7%0.8%
CompanyRev. GrowthGross MarginEBITDA MarginNet Margin
EBO1.7%14.0%4.3%1.8%
SIG45.7%5.5%0.9%-0.3%
Industry median11.4%5.5%1.7%0.8%

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
02.5 B5 B7.5 B202020212022202320242025

Capital Structure

Q2 2025
Total Assets8.8 B
  • Equity3.2 B NZD36%
  • Current Liabilities3.1 B NZD36%
  • Long-term Liabilities2.5 B NZD28%

Key Figures

YoY change
Total Assets8.8 B NZD+17.7%
Total Liabilities5.7 B NZD+14.3%
Total Equity3.2 B NZD+25.2%
Cash & ST Investments290.3 M NZD-26.3%
Total Debt2.6 B NZD+32.1%
Net Debt2.3 B NZD+46.6%

Peer Comparison· Medical Distribution

CompanyCurrent RatioDebt/EquityNetDebt/EBITDAEquity/Assets
EBO1.2481.9%3.8536.3%
SELEC1.3717.7%-1.2835.3%
HSIC1.36114.8%3.6028.9%
CAH0.91-314.8%1.65-5.0%
COR0.95364.5%2.034.2%
MCK0.85-396.6%0.66-2.6%
Industry median1.2417.7%2.0328.9%
CompanyCurrent RatioDebt/EquityNetDebt/EBITDAEquity/Assets
EBO1.2481.9%3.8536.3%
SIG1.5915.8%2.8245.8%
Industry median1.2417.7%2.0328.9%

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
0200 M400 M202020212022202320242025

Cash Flow Bridge

Q2 2025 · TTM
0200 M400 M399.7 M NZDOperating-422.8 M NZDInvesting148.4 M NZDFinancing125.3 M NZDNet Change

Key Figures

YoY change
Operating Cash Flow399.7 M NZD—
Capital Expenditures63.1 M NZD—
Free Cash Flow229.9 M NZD—
Dividends Paid-143 M NZD—

Peer Comparison· Medical Distribution

CompanyCF MarginFCF MarginCapEx RatioCF/Net Income
EBO2.8%1.6%0.4%160.0%
SELEC0.4%1.0%0.3%68.3%
HSIC4.3%3.2%1.1%146.3%
CAH2.0%1.8%0.2%321.3%
COR0.7%0.5%0.2%89.3%
MCK1.5%1.5%0.1%129.3%
Industry median1.5%1.5%0.2%146.3%
CompanyCF MarginFCF MarginCapEx RatioCF/Net Income
EBO2.8%1.6%0.4%160.0%
SIG-6.5%-6.7%0.2%2,280.0%
Industry median1.5%1.5%0.2%146.3%

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on EBO

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 7, 26. This content is for informational purposes only and is not investment advice.